Palvella Therapeutics, Inc. (PVLA) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, Palvella Therapeutics, Inc. (NASDAQ:PVLA) is held by 100 institutional firms.

• The collective stake of institutional investors in Palvella Therapeutics moved to 77.1% in September 2025, a shift up from the 53.5% reported for June 2025.
• The company experienced a 56.52% quarterly change in institutional shares held, alongside an increase of 316.67% in total owners annually.
• The latest 13F cycle for Palvella Therapeutics reveals that of 100 total investors, 65 funds grew their exposure, whereas 21 reduced theirs and 14 made no changes.
• The total number of shares held by institutions in Palvella Therapeutics increased to 8.53Mn as of September 2025, a net change of up by 3.08Mn shares quarter on quarter, and up 7.92Mn shares year over year.
• The top institutional stake in Palvella Therapeutics as of September 30, 2025 belongs to BVF INC/IL, which owns 1.16Mn shares, or 10.50% of the company.
• Among the most significant buyers of Palvella Therapeutics during September 2025 were First Light Asset Management, LLC (541.54K), BVF INC/IL (464.69K), PERCEPTIVE ADVISORS LLC (395.09K), FEDERATED HERMES, INC. (339.05K), VANGUARD GROUP INC (330.85K).
• Leading sellers of Palvella Therapeutics stock in September 2025 included MILLENNIUM MANAGEMENT LLC (288.12K), Samsara BioCapital, LLC (130.11K), Woodline Partners LP (99.87K), SECTORAL ASSET MANAGEMENT INC (46.50K), Blue Owl Capital Holdings LP (30.00K).
• The top 10 institutional holders of Palvella Therapeutics for the quarter ending September 2025 included BVF INC/IL (1.16Mn), SUVRETTA CAPITAL MANAGEMENT, LLC (822.40K), Frazier Life Sciences Management, L.P. (722.40K), First Light Asset Management, LLC (541.54K), VANGUARD GROUP INC (494.66K), BlackRock, Inc. (487.62K), PERCEPTIVE ADVISORS LLC (395.09K), Woodline Partners LP (345.75K), FEDERATED HERMES, INC. (339.05K), Point72 Asset Management, L.P. (317.31K).